Wednesday, August 21st | 21 Av 5779

Subscribe
August 11, 2019 9:32 am

Israeli Medical Aesthetic Device Manufacturer InMode Raises $70 Million on Nasdaq IPO

avatar by Golan Hazani / CTech

The Nasdaq broadcasting studio. Photo: Italia all’ONU via Wikicommons.

CTech – Israel-based InMode Aesthetic Solutions has raised $70 million on its Nasdaq initial public offering Thursday, listing under the ticker INMD. InMode priced its shares at $14, the lower end of its previously suggested range, giving the company a pre-money valuation of $378 million. The company closed 3.3 percent up on Friday.

InMode develops medical aesthetic devices using radio-frequency energy technology, which can penetrate subdermal fat. The company’s main markets are Europe and the US, and it is headquartered in Lake Forest, California, with a research and development center in Israel and offices in Canada. For 2018, InMode reported revenues of $100 million, up from $53.5 million in 2017, and a net income of $22.3 million. For the first three months of 2019, the company reported revenues of $30.5 million and a net income of $10.16 million.

InMode was founded as Invasix in 2008 by CEO and chairman Moshe Mizrahi, one of the founders of Israel-based medical device company Syneron Medical. Prior to the IPO, Mizrahi held a 20.6 percent stake in InMode. In 2006, Mizrahi co-founded home aesthetics device developer Home Skinovations, which he previously tried to list three times, the latest earlier this year according to a $300 million company valuation.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.